Ganot Ilan — SEC insider filings
SEC reporting owner CIK 1727460. 35 insider filings on record with FilingPulse; latest filed 2026-10-26.
Transaction summary — filings shown
Covers all 35 filings on record, filed 2020-08-14 to 2026-10-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 18 legs across 17 filings — 32,981 shares, $190,381 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 68.
- Largest priced transaction: sale of 10,713 shares @ $6.14 ($65,776) in Solid Biosciences Inc., filed 2021-01-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | Director | 35 | — | 18 legs · 32,981 sh · $190,381 | 68 |
Insider filings — Ganot Ilan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-26 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 77,500 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 4,861 · Sale (S): 2,658 @ $5.82 · Option exercise (M): 4,861 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Solid Biosciences Inc. (SLDB) | Sale (S): 7,205 @ $6.44 | EDGAR |
| 2026-02-02 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 15,000 · Grant/award (A): 70,900 (derivative) @ $0 · Grant/award (A): 35,450 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 389 · Sale (S): 191 @ $6.59 · Option exercise (M): 3,884 · Option exercise (M): 389 (derivative) @ $0 · Option exercise (M): 3,884 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 2,994 · Sale (S): 1,053 @ $5.43 · Option exercise (M): 2,994 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Solid Biosciences Inc. (SLDB) | Sale (S): 3,278 @ $4.12 | EDGAR |
| 2025-08-18 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 18,750 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 77,500 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 4,861 · Sale (S): 1,711 @ $3.96 · Option exercise (M): 4,861 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 388 · Sale (S): 144 @ $3.11 · Option exercise (M): 3,883 · Option exercise (M): 388 (derivative) @ $0 · Option exercise (M): 3,883 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 2,994 · Sale (S): 1,056 @ $4.31 · Option exercise (M): 2,994 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 34,400 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 1,553 · Sale (S): 462 @ $10.33 · Option exercise (M): 1,553 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 19,444 (derivative) @ $0 | EDGAR |
| 2024-01-30 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 388 · Sale (S): 139 @ $7.99 · Option exercise (M): 3,883 · Option exercise (M): 388 (derivative) @ $0 · Option exercise (M): 3,883 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 2,993 · Sale (S): 1,142 @ $5.30 · Option exercise (M): 2,993 (derivative) @ $0 | EDGAR |
| 2023-12-05 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 1,583 · Option exercise (M): 1,583 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 1,583 · Option exercise (M): 1,583 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 1,553 · Sale (S): 487 @ $4.85 · Option exercise (M): 1,583 · Option exercise (M): 1,553 (derivative) @ $0 · Option exercise (M): 1,583 (derivative) @ $0 · Grant/award (A): 9,650 (derivative) @ $0 | EDGAR |
| 2023-03-06 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 1,584 · Option exercise (M): 1,584 (derivative) @ $0 | EDGAR |
| 2023-01-31 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 388 · Sale (S): 141 @ $7.49 · Option exercise (M): 3,883 · Sale (S): 1,382 @ $7.49 · Option exercise (M): 388 (derivative) @ $0 · Option exercise (M): 3,883 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 23,950 (derivative) @ $0 · Grant/award (A): 11,975 (derivative) @ $0 | EDGAR |
| 2022-12-05 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 13,333 (derivative) @ $0 · Grant/award (A): 6,333 (derivative) @ $0 | EDGAR |
| 2022-05-04 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 46,600 (derivative) @ $0 | EDGAR |
| 2022-03-08 | 4 | Solid Biosciences Inc. (SLDB) | Sale (S): 463 @ $1.12 | EDGAR |
| 2022-01-31 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 466,000 (derivative) @ $0 · Grant/award (A): 233,000 (derivative) @ $0 · Grant/award (A): 46,400 (derivative) @ $0 · Grant/award (A): 23,300 (derivative) @ $0 | EDGAR |
| 2021-02-16 | 4 | Solid Biosciences Inc. (SLDB) | Sale (S): 457 @ $7.66 | EDGAR |
| 2021-01-29 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 35,500 · Sale (S): 10,713 @ $6.14 · Option exercise (M): 35,500 (derivative) @ $0 | EDGAR |
| 2021-01-27 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 438,000 (derivative) @ $0 · Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2020-12-14 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 27,027 @ $3.70 | EDGAR |
| 2020-09-14 | 4/A | Solid Biosciences Inc. (SLDB) | Grant/award (A): 1,350 (derivative) @ $0 | EDGAR |
| 2020-08-14 | 4 | Solid Biosciences Inc. (SLDB) | Option exercise (M): 800 · Sale (S): 299 @ $2.44 · Option exercise (M): 800 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1727460 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs